Radiopharmacology is the branch of pharmacology that specializes in these radiocompounds. The main group of these compounds are the radiotracers used to diagnose dysfunction in body tissues. While not all medical isotopes are radioactive, radiopharmaceuticals are the oldest and still most common such drugs. Radiopharmaceuticals, or medicinal radiocompounds or nuclear medicines, are a group of pharmaceutical drugs which have radioactivity. These nuclear medicines can be used for diagnostic as well as therapeutic applications. Radiopharmaceuticals emit radiation themselves, which is different from contrast media which absorb or alter external electromagnetism or ultrasound.
Radiopharmaceuticals Market to 2027 - Global Analysis and Forecasts By Applications (Diagnostic Applications, Therapeutic Applications); End User (Hospitals, Diagnostic Centers)
The reports cover key developments in the radiopharmaceuticals market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from radiopharmaceuticals market are anticipated to lucrative growth opportunities in the future with the rising demand for radiopharmaceuticals market in the global market. Below mentioned is the list of few companies engaged in the radiopharmaceuticals market.
Get Sample Copy at https://www.theinsightpartners.com/sample/TIPRE00003751
The report also includes the profiles of key radiopharmaceuticals market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- CARDINAL HEALTH INC.
- GENERAL ELECTRIC COMPANY
- IBA GROUP
- LANTHEUS MEDICAL IMAGING
- COVIDIEN PLC
- POSITRON CORPORATION
- NTP RADIOISOTOPES PTY LTD.
- BRACCO IMAGING
- ADVANCED ACCELERATOR APPLICATIONS
The radiopharmaceuticals market is anticipated to grow in the forecast, owing to the factors such increasing incidence and prevalence of target conditions, alpha radioimmunotherapy-based targeted cancer treatment and initiatives to lessen the demand-supply gap of Mo-99 in the market during the forecast period. However short life of the radiopharmaceuticals is hampering the market growth.
The "Global Radiopharmaceuticals Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of radiopharmaceuticals market with detailed market segmentation by applications, end user and geography. The global radiopharmaceuticals market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading radiopharmaceuticals market players and offers key trends and opportunities in the market.
Browse Complete Report at https://www.theinsightpartners.com/reports/radiopharmaceuticals-marketContact us –
Contact Person : Sameer Joshi
Phone : +1-646-491-9876
Email Id : firstname.lastname@example.org
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Media, Healthcare and Telecommunication industries.